25 February 2025
25 February 2025
In an anonymous post in the BMJ, the author claims that banned words such as diversity or bias could lead to grants being taken away.
The company's IPO follows a $182m Series C funding round last year.
Summit’s PD-1 bispecific antibody outperformed MSD’s Keytruda in a Phase III trial enrolling patients with lung cancer.
The applications are backed by data from the company-conducted Phase III trials.
PHARMAP 2025 will take place on 14-15 April 2025 in Berlin, Germany.
The sBLA submission is supported by outcomes from the Phase III CheckMate -8HW trial.
The EC’s decision was underpinned by a data set and evidence totality, which included findings from a Phase III trial.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
